Melinta Therapeutics (CEMP) Inventory Turnover Ratio, from third quarter 2019 to third quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Melinta Therapeutics, Inc.  (CEMP)
 

Melinta Therapeutics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Melinta Therapeutics's inventory turnover ratio, the ratio that measures Melinta Therapeutics's ability to manage its supply chain, sequentially decreased to 0.79 in the third quarter 2019, which does not come as a surprise, as the Melinta Therapeutics continue to experience headwinds, which also impact its supply chain. Melinta Therapeutics's average inventory processing period in the Sep 30 2019 quarter, has increased to 462 days, from 388 days, in the Jun 30 2019 quarter.

Within Healthcare sector 372 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2019, to 2060, from total ranking in the second quarter 2019 at 2124.

CEMP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Melinta Therapeutics, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CEMP Inventory Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter
Y / Y Inventory Growth 9.01 % 23.8 % 57.52 % 281.9 % -
Y / Y Cost of Sales Growth -38.68 % -21.39 % -4.18 % - -
Inventory Turnover Ratio (TTM) 0.79 0.94 1.05 1.18 1.18
CEMP's Total Ranking # 2060 # 2124 # 1996 # 2135 # 2060
Average inventory processing period 459 390 349 310 310
Seq. Inventory Growth -6.58 % -5.42 % 7.52 % 14.75 % 6.09 %
Seq. Cost of Sales Growth -4.93 % 17.3 % -18.07 % -32.88 % 21.88 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 123
Healthcare Sector # 373
Overall Market # 2060

Inventory Turnover Ratio Statistics
High Average Low
1.18 1.03 0.79
(Dec 31 2018)   (Sep 30 2019)



CEMP Company Profile >> Back to CEMP Efficiency Comparisons >> Compare CEMP Inventory Turnover Ratio to its Competitors

Financial Statements
Melinta Therapeutics's Inventories $ 39 Millions Visit CEMP's Balance sheet
Melinta Therapeutics's Cost of Revenues TTM $ 33 Millions Visit CEMP's Income Statement
What are CEMP's Sales? Visit CEMP's Sales by Segment

Other Inventory Turnover Ratios
Melinta Therapeutics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CEMP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CEMP's Competitors
Inventory Turnover Ratio for CEMP's Suppliers
Inventory Turnover Ratio for CEMP's Customers

You may also want to know
CEMP's Sales Growth Rates CEMP's Pe Price to earnings ratio CEMP's Receivables Turnover Ratio CEMP's Stock Quote
CEMP's Net Income Growth Rates CEMP's Ps Price to Sales ratio CEMP's Sales per Employee CEMP's Asset Turnover Ratio
CEMP's Net Margin CEMP's Pb Price to Book ratio CEMP's Financial Strength Ratios CEMP's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2019 Inventories at quarter ending Sep 30 2019
Boston Scientific Corporation  2.27 $ 2,937.000  Millions$ 1,292  Millions
Qc Technologies Inc   2.26 $ 1.213  Millions$ 1  Millions
Milestone Scientific Inc   2.25 $ 3.759  Millions$ 2  Millions
Scientific Industries Inc   2.25 $ 5.764  Millions$ 3  Millions
Neos Therapeutics Inc   2.25 $ 25.705  Millions$ 11  Millions
Orasure Technologies Inc  2.23 $ 55.733  Millions$ 25  Millions
Glaukos Corp  2.23 $ 29.802  Millions$ 13  Millions
Inspiremd Inc   2.21 $ 2.806  Millions$ 1  Millions
Vystar Corporation  2.21 $ 3.924  Millions$ 2  Millions
Staar Surgical Co  2.21 $ 36.366  Millions$ 16  Millions
China Pharma Holdings Inc  2.20 $ 10.096  Millions$ 5  Millions
Biodelivery Sciences International Inc   2.20 $ 18.348  Millions$ 8  Millions
Nature s Sunshine Products inc   2.20 $ 95.617  Millions$ 44  Millions
Amphastar Pharmaceuticals Inc   2.19 $ 195.614  Millions$ 89  Millions
Beone Medicines Ltd   2.15 $ 62.399  Millions$ 29  Millions
Avanos Medical Inc   2.15 $ 284.800  Millions$ 132  Millions
Viewray Inc   2.15 $ 92.920  Millions$ 43  Millions
Cv Sciences Inc   2.15 $ 18.343  Millions$ 9  Millions
Amicus Therapeutics inc   2.15 $ 19.362  Millions$ 9  Millions
Cryo cell International Inc   2.13 $ 10.359  Millions$ 5  Millions
Harvard Bioscience Inc   2.11 $ 53.234  Millions$ 25  Millions
Luminex Corporation  2.11 $ 144.055  Millions$ 68  Millions
Accuray Incorporated  2.11 $ 254.818  Millions$ 121  Millions
Biolase Inc   2.09 $ 25.178  Millions$ 12  Millions
Livanova Plc  2.07 $ 336.245  Millions$ 163  Millions
Oxford Immunotec Global Plc  2.06 $ 19.315  Millions$ 9  Millions
Sarepta Therapeutics Inc   2.04 $ 301.034  Millions$ 147  Millions
Endologix Inc  2.02 $ 61.689  Millions$ 31  Millions
Thermogenesis Holdings Inc   2.00 $ 8.086  Millions$ 4  Millions
Meridian Bioscience Inc   2.00 $ 82.689  Millions$ 41  Millions

Date modified: 2026-09-26T06:56:48+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.